Supply Chain Intelligence

Valneva SE Supply Chain

VALN supply chain intelligence for Valneva SE: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

VALN ·Last updated 2026-07-30 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

4Suppliers
3Customers
1Debt Items
20Related Chains

Valneva SE Suppliers

TickerNameConfidenceEvidence
LIMMATECH-BIOLOGICS LIMMATECH-BIOLOGICS 90% We have in-licensing agreements relating to certain of our products and product candidates, including with LimmaTech Biologics for S4V2 (Shigella).
KMDA Kamada Ltd. 72% Reciprocal relationship from KMDA graph: tici S.p.A, Bio Products Laboratories (“BPL”) and Valneva SE, which are sold in our Distribution segment, together represented approximately 8%, 18% and 20% o…
SNYNF Sanofi 72% en and Kaketsuken (Japan), both with inactivated vero-cell based vaccines, Chengdu (China and GAVI/UNICEF markets) with a live-attenuated vaccine, and Sanofi’s live-attenuated chimeric vaccine, IMOJE…
SNYNF Sanofi 72% Reciprocal relationship from SNYNF graph: Reciprocal relationship from VALN graph: en and Kaketsuken (Japan), both with inactivated vero-cell based vaccines, Chengdu (China and GAVI/UNICEF markets) w…

Valneva SE Customers

TickerNameConfidenceEvidence
KMDA Kamada Ltd. 72% Reciprocal relationship from KMDA graph: Reciprocal relationship from VALN graph: Reciprocal relationship from KMDA graph: tici S.p.A, Bio Products Laboratories (“BPL”) and Valneva SE, which are sold…
SNYNF Sanofi 72% en and Kaketsuken (Japan), both with inactivated vero-cell based vaccines, Chengdu (China and GAVI/UNICEF markets) with a live-attenuated vaccine, and Sanofi’s live-attenuated chimeric vaccine, IMOJE…
SNYNF Sanofi 72% Reciprocal relationship from SNYNF graph: Reciprocal relationship from VALN graph: Reciprocal relationship from SNYNF graph: Reciprocal relationship from VALN graph: en and Kaketsuken (Japan), both w…

Valneva SE Debt Obligations

InstrumentDescriptionConfidenceEvidence
VALN-DEBT Debt stack $243.8M 90% Market cache reports total debt of $243.8M.

Valneva SE Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Valneva SE.

Valneva SE Ownership

HolderNameConfidenceEvidence
VALN-OWNER-FRAZIER-LIFE-SCIENCES-MANAGEMENT Frazier Life Sciences Management, L.P. 90% 13F overlay lists Frazier Life Sciences Management, L.P. as top holder; 23 tracked holders.

Valneva SE Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
CALC CalciMedica, Inc. 100.00 2
SVA Sinovac Biotech Ltd. 100.00 2
EDIT Editas Medicine, Inc. 100.00 2
REGN Regeneron Pharmaceuticals, Inc. 100.00 2
CTMX CytomX Therapeutics, Inc. 100.00 2
DBVTF DBV TECHNOLOGIES 100.00 2
WHWK Whitehawk Therapeutics, Inc. 100.00 2
ALXO ALX Oncology Holdings Inc. 100.00 2
ATOS Atossa Therapeutics, Inc. 100.00 2
BIOA BioAge Labs, Inc. 100.00 2
CYTK Cytokinetics, Incorporated 100.00 2
CBIO Crescent Biopharma, Inc. 100.00 2
ANL Adlai Nortye Ltd. 100.00 2
BLRX BioLineRx Ltd. 100.00 2
ANRO Alto Neuroscience, Inc. 100.00 2
CCEP Coca-Cola Europacific Partners PLC 100.00 2
DSGN Design Therapeutics, Inc. 100.00 2
AZN AstraZeneca PLC 100.00 2
CYTOF Altamira Therapeutics Ltd. 100.00 2
GRDX GridAI Technologies Corp. 100.00 2
View VALN supply chain intel →

Explore the full interactive supply chain map for Valneva SE.

Open VALN supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map